OpiCalc Logo

OpiCalc

805 Clinical Tools

Logo
OpiCalc
7-Point Dermoscopy ChecklistABSI (Burn Severity)AGEP ScoreAJCC Melanoma StagingALDEN AlgorithmBWH SCC StagingBody Surface Area (BSA)Breslow & Clark MicrostagingCTCAE Skin ToxicityDLQIEASI ScoreGAGS (Acne)HiSCRIGAIHS4Lund-Browder ChartMSK Melanoma NomogramMelanoma Risk ScreeningPASI ScorePOEMParkland FormulaRegiSCAR DRESS ValidationRevised Baux ScoreSCORADSCORTENmPASI
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

MissionPrivacyTerms

IHS4

International HS Severity Score (IHS4): A dynamic tool for grading Hidradenitis Suppurativa severity at point-of-care.
Inflammatory Nodules
0

× 1 point

Abscesses
0

× 2 points

Draining Tunnels
0

× 4 points

Guidelines & Evidence

Clinical Details

Section 1

When to Use

When to Use

Quantifying the dynamic severity of Hidradenitis Suppurativa (HS).
Superior to Hurley staging for monitoring treatment response.
Section 2

Formula & Logic

Scoring Algorithm

Points = (Nodules × 1) + (Abscesses × 2) + (Tunnels/Draining Sinuses × 4).
Section 3

Pearls/Pitfalls

Severity Categories

≤3: Mild
4-10: Moderate
≥11: Severe
Section 4

Next Steps

Management Shift

Moderate to Severe IHS4 scores frequently require systemic adalimumab or other biologics as per international guidelines.
Section 5

Evidence Appraisal

Primary Reference

Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4).

Zouboulis CC et al. • Br J Dermatol. 2017;177(5):1401-1409

Last Comprehensive Review: 2026

Related Dermatology Tools

ALDEN Algorithm
Body Surface Area
Breslow & Clark Microstaging
BWH SCC Staging
CTCAE Skin Toxicity
DLQI
EASI Score
GAGS
HiSCR
IGA
Have feedback about this calculator?Let us know.